secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2025-09-10T23:59:59+00:00
Accession:  0001641172-25-027052
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TNF Pharma closes $7M private placement at 44% premium; closes LPU acquisition
------------------------------------------------------------------------------

- Closed $7M private placement of 7,000 Series H preferred shares convertible to 1.4M common at $5.00/share, plus warrants for 1.4M shares at $5.00.
- Conversion/exercise limited pending stockholder approval; placement agents include Rodman & Renshaw, H.C. Wainwright, and GPN.
- Closed acquisition of LPU Holdings LLC, issuing Series I preferred stock convertible into 747,362 common shares.
- Extended maturity of Series F and F-1 preferred stock to March 2, 2027 and removed amortization payments.
- Common shares outstanding: 1,846,930 as of September 3, 2025; company plans to fund blockchain accelerator development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000164117225027052/0001641172-25-027052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000164117225027052/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-027052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer